Pass the ACDIS Clinical Documentation Specialist CCDS Questions and answers with ExamsMirror

The provider's response should be respected unless new information or a genuine unresolved documentation issue creates a legitimate reason for additional clarification.

“Clinically unable to determine” is an acceptable professional conclusion when the available evidence does not permit the provider to confidently establish a diagnosis. A CDI specialist must not continue sending essentially the same query simply because a different response would produce more favorable reimbursement.

Likewise, CDI cannot alter the provider's response or instruct coding personnel to assign a diagnosis that the provider declined to establish.

The 2026 ACDIS/AHIMA Guidelines for Achieving a Compliant Query Practice supersede all previous versions and serve as the current foundational resource for query processes. The query process is intended to improve the accuracy, completeness, and integrity of documentation—not to secure a predetermined financial result.

A legitimate follow-up could occur if new laboratory values, operative findings, transfusion information, pathology, or other material information emerges after the original response and creates a materially different clarification question.

Professional CDI practice requires balancing clinical advocacy with provider autonomy, ethical conduct, and regulatory compliance.

CCDS Reference Topics: Provider query responses; ethical CDI practice; repeated queries; provider independence; compliance.

=========

The appropriate action is to query for clarification. A temporal relationship—anemia occurring after surgery—does not automatically establish that a reportable complication occurred. Likewise, a CDI specialist cannot independently translate a substantial hemoglobin decline into acute posthemorrhagic anemia without provider documentation.

The FY 2026 Official Guidelines state that complication-of-care code assignment depends on provider documentation establishing the relationship between the condition and the care or procedure unless the classification specifically instructs otherwise. They also emphasize that not every condition occurring during or following medical care is a complication.

The query could present the preoperative and postoperative hemoglobin values, estimated blood loss, transfusions, clinical monitoring, and treatment. Appropriate response options might include acute blood loss anemia, expected postoperative anemia, another diagnosis, or clinically unable to determine, depending on the record.

Option A overstates causation. Option B independently diagnoses the patient from laboratory findings. Option D is equally inappropriate because clinically significant postoperative anemia may be reportable.

CCDS Reference Topics: Complications of care; postoperative anemia; clinical indicators; cause-and-effect clarification; compliant querying.

=========

Megestrol acetate is the correct choice. This item is adapted from an official ACDIS CCDS sample question in the Candidate Handbook, where Megace—megestrol acetate—is identified as the appropriate appetite-stimulating medication.

Megestrol acetate is a synthetic progestational agent with recognized appetite-stimulating effects. Current U.S. prescribing information specifically identifies megestrol acetate oral suspension for anorexia, cachexia, or significant unexplained weight loss in patients with AIDS. Its use illustrates why CDI specialists need functional knowledge of pharmacology: medication profiles can provide clinically relevant clues to diagnoses under evaluation, although a medication alone never establishes a reportable diagnosis.

Memantine is primarily used in Alzheimer's disease and is not an appetite stimulant. Levothyroxine replaces thyroid hormone in hypothyroidism. Sibutramine was historically used for weight reduction rather than cachexia and is therefore directionally opposite to the desired effect.

In CDI review, identification of megestrol may prompt assessment of the record for malnutrition, cachexia, malignancy-related weight loss, HIV-associated wasting, or another underlying cause, but the provider must document the diagnosis.

CCDS Reference Topics: Pharmacology; cachexia; nutrition disorders; clinical indicators.

=========

The 38% post-discharge query rate represents the clearest workflow opportunity because a large proportion of clarification is occurring after the concurrent hospitalization period.

A 97% provider response rate reflects strong physician participation, while a 96% CDI/coder agreement rate indicates substantial alignment between concurrent CDI review and final coding. An 84% agreement rate is not inherently problematic because providers must remain free to disagree with a query based on their clinical judgment.

A high retrospective-query percentage can indicate that cases are being reviewed too late, that certain documentation opportunities are not recognized during hospitalization, that discharge documentation introduces unresolved diagnoses, or that staffing/workflow does not adequately prioritize cases before discharge.

A CDI manager should drill further into the metric by service line, query type, day of stay, weekday/weekend discharge, provider group, and reason for retrospective clarification. This analysis helps distinguish unavoidable retrospective queries from remediable process problems.

The objective is not to eliminate every post-discharge query. Some documentation issues become apparent only after final testing, pathology, procedures, or discharge summaries are completed.

CCDS Reference Topics: CDI program metrics; concurrent versus retrospective review; workflow analysis; performance improvement.

=========

The clinical findings strongly support clarification of hyponatremia. A serum sodium concentration of 119 mEq/L represents substantial reduction below the usual reference range, and neurologic manifestations such as confusion are consistent with clinically significant hyponatremia. Administration of hypertonic saline and frequent sodium monitoring further demonstrate that the electrolyte abnormality is clinically important.

The CDI specialist should not independently assign the diagnosis based solely on the laboratory result. Instead, the abnormal sodium level, neurologic symptoms, and targeted therapy provide an appropriate clinical basis for a neutral provider query.

Hypernatremia represents elevated serum sodium and therefore contradicts the laboratory finding. Hyperkalemia relates to potassium rather than sodium. Metabolic alkalosis is an acid-base disturbance requiring supporting blood-gas and chemistry findings and is not established by the information provided.

Further specificity may also matter. Depending on the clinical record, the physician may determine that the hyponatremia is related to SIADH, volume depletion, medication use, heart failure, cirrhosis, or another etiology.

The CCDS role is to recognize the clinical significance of laboratory abnormalities and obtain clinically meaningful provider documentation rather than simply translating abnormal values into diagnoses.

CCDS Reference Topics: Electrolyte abnormalities; hyponatremia; laboratory interpretation; clinical indicators; documentation clarification.

=========

For a pregnant patient, the first coding consideration is the Chapter 15 obstetric guideline unless the provider explicitly documents that the pregnancy is incidental to the encounter. ICD-10-CM codes from O00-O9A have sequencing priority over codes from other chapters when a condition complicates pregnancy, childbirth, or the puerperium.

Therefore, although the patient's underlying clinical disease is Clostridium difficile enteritis, the principal-diagnosis analysis begins with the applicable pregnancy-complication code. An additional infectious-disease code would then be used as appropriate to identify the specific infection. The infectious and parasitic disease chapter does not override the obstetric sequencing rules.

Signs such as diarrhea, cramps, nausea, and vomiting are also not the principal coding focus once a definitive diagnosis—C. difficile enteritis—has been established. Similarly, an etiology/manifestation sequencing convention is not the controlling rule in this scenario.

The critical CCDS concept is recognition of chapter-specific sequencing rules. A CDI specialist reviewing pregnant patients must recognize that otherwise standard principal-diagnosis logic may be superseded by obstetric instructions.

CCDS Reference Topics: Official Guidelines for Coding and Reporting—Chapter 15; principal diagnosis selection; chapter-specific sequencing.

=========

CMS PSI 90, the Patient Safety and Adverse Events Composite, is one of the six measures used in the FY 2026 HAC Reduction Program.

CMS states that the program uses one claims-based patient-safety composite—PSI 90—plus five healthcare-associated infection measures: CLABSI, CAUTI, colon and abdominal hysterectomy surgical-site infection, MRSA bacteremia, and C. difficile infection.

Case mix index is an MS-DRG resource-intensity statistic and is not a HACRP quality measure. Query-response rate is an internal CDI performance metric. Patient-experience measures belong to other CMS quality frameworks, including Hospital VBP, rather than constituting a HACRP measure.

For FY 2026, hospitals with Total HAC Scores above the 75th percentile—effectively the worst-performing quartile—are subject to a 1% payment reduction under the program.

A CDI specialist should also distinguish HACRP from the separate HAC/POA payment provision. CMS explicitly identifies them as distinct programs, even though both involve hospital-acquired conditions.

CCDS Reference Topics: HACRP; PSI 90; healthcare-associated infections; patient safety; quality reimbursement.

=========

This scenario requires a clinical validation query. The diagnosis of respiratory failure is documented, but the remainder of the record lacks clinical evidence supporting it. CDI should not automatically accept the diagnosis solely because it appears in a progress note, nor should the specialist unilaterally remove or invalidate the provider's diagnosis.

The appropriate process is to present relevant patient-specific clinical information objectively and ask the responsible provider to clarify whether respiratory failure remains clinically appropriate. A compliant validation query should permit the provider to confirm the diagnosis, document another condition, indicate that it was ruled out, or provide another clinically appropriate response.

Looking only for CPAP documentation is inadequate because CPAP can be used for multiple conditions and its presence or absence does not independently determine whether respiratory failure exists. Similarly, simply refusing to code the diagnosis without seeking clarification bypasses the provider's clinical judgment and the organization's validation process.

The 2026 ACDIS/AHIMA query guidance is now the current foundational standard and supersedes earlier versions of the practice brief.

CCDS Reference Topics: Clinical validation; compliant querying; unsupported diagnoses; documentation integrity.

=========

Prior-encounter information may provide valuable clinical context, but it should not automatically be imported as a current reportable diagnosis without considering whether the condition remains active and relevant to the present encounter.

Here, a prior diagnosis of chronic systolic heart failure, ongoing heart-failure therapy, and ambiguous current wording such as “history of CHF” create a reasonable opportunity to clarify the patient's current heart-failure status if that information is clinically relevant.

The CDI specialist should not independently carry forward the previous diagnosis or escalate it to acute heart failure. Conversely, rigidly ignoring reliable prior clinical information can prevent identification of legitimate documentation gaps.

The 2026 ACDIS/AHIMA query guidance specifically includes the role of prior encounters as part of its updated query-practice framework, while emphasizing compliant provider clarification and accurate representation of the current patient's clinical status.

A query should make clear which current clinical indicators support the need for clarification and should not imply that a previous diagnosis must automatically remain valid.

CCDS Reference Topics: Prior encounters; chronic conditions; heart failure; query practice; current-encounter documentation.

=========

The laboratory trajectory strongly supports consideration of acute kidney injury (AKI). The creatinine increased from 0.9 to 1.5 mg/dL, an absolute increase of 0.6 mg/dL over 48 hours and approximately 1.67 times the baseline value. Combined with decreased urine output, this represents a clinically significant acute change in renal function.

The key distinction is the acute change from baseline. A single creatinine value cannot reliably establish AKI because renal function must be interpreted in context, including baseline creatinine, fluid status, urine output, medications, hemodynamics, and other contributing factors.

Chronic kidney disease requires evidence of persistent kidney abnormality over time rather than an isolated rapid deterioration. End-stage renal disease represents advanced irreversible kidney failure and is not supported by this scenario. Nephrotic syndrome is characterized by a different constellation including heavy proteinuria, hypoalbuminemia, and edema.

The CDI specialist should not independently diagnose AKI. Instead, the laboratory trend and reduced urine output create an appropriate basis for a provider query when no corresponding diagnosis has been documented.

CCDS Reference Topics: Renal pathophysiology; AKI clinical indicators; baseline comparison; diagnostic clarification.

=========